280 related articles for article (PubMed ID: 27733759)
21. B cell biology: implications for treatment of systemic lupus erythematosus.
Anolik JH
Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
[TBL] [Abstract][Full Text] [Related]
22. Editorial: Cutting edge in systemic lupus erythematosus.
D'Cruz DP; Kuhn A
Immunol Res; 2017 Apr; 65(2):429-431. PubMed ID: 28303447
[No Abstract] [Full Text] [Related]
23. [New therapeutic approaches to autoimmune diseases].
Amoura Z; Piette JC
Presse Med; 2006 Apr; 35(4 Pt 2):709-13. PubMed ID: 16614619
[TBL] [Abstract][Full Text] [Related]
24. Belimumab for systemic lupus erythematosus: a practice-based view.
Parodis I; Axelsson M; Gunnarsson I
Lupus; 2013 Apr; 22(4):372-80. PubMed ID: 23553780
[TBL] [Abstract][Full Text] [Related]
25. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.
Mosak J; Furie R
Lupus; 2013 Apr; 22(4):361-71. PubMed ID: 23553779
[TBL] [Abstract][Full Text] [Related]
26. B-cell-directed therapies in systemic lupus erythematosus.
Tieng AT; Peeva E
Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
[TBL] [Abstract][Full Text] [Related]
27. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
Levesque MC; St Clair EW
J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
[TBL] [Abstract][Full Text] [Related]
28. The immunological basis of B-cell therapy in systemic lupus erythematosus.
Mok MY
Int J Rheum Dis; 2010 Feb; 13(1):3-11. PubMed ID: 20374380
[TBL] [Abstract][Full Text] [Related]
29. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.
Lenert A; Lenert P
Drug Des Devel Ther; 2015; 9():333-47. PubMed ID: 25609919
[TBL] [Abstract][Full Text] [Related]
30. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events.
Murdaca G; Colombo BM; Puppo F
Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271
[TBL] [Abstract][Full Text] [Related]
31. Post-marketing experiences with belimumab in the treatment of SLE patients.
Askanase AD; Yazdany J; Molta CT
Rheum Dis Clin North Am; 2014 Aug; 40(3):507-17, viii. PubMed ID: 25034159
[TBL] [Abstract][Full Text] [Related]
32. [Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].
Takasaki Y
Nihon Jinzo Gakkai Shi; 2012; 54(5):598-602. PubMed ID: 22991839
[No Abstract] [Full Text] [Related]
33. [Physiopathology of systemic lupus erythematosus: a 2014 update].
Mathian A; Arnaud L; Amoura Z
Rev Med Interne; 2014 Aug; 35(8):503-11. PubMed ID: 24262408
[TBL] [Abstract][Full Text] [Related]
34. A new perspective on therapies involving B-cell depletion in autoimmune diseases.
Al-Hawary SIS; Jasim SA; Hjazi A; Ullah H; Bansal P; Deorari M; Sapaev IB; Ami AA; Mohmmed KH; Abosaoda MK
Mol Biol Rep; 2024 May; 51(1):629. PubMed ID: 38717637
[TBL] [Abstract][Full Text] [Related]
35. Lupus: novel therapies in clinical development.
Chugh PK
Eur J Intern Med; 2012 Apr; 23(3):212-8. PubMed ID: 22385876
[TBL] [Abstract][Full Text] [Related]
36. [Novel therapeutic possibilities in systemic lupus erythematosus].
Bazsó A; Poór G; Gergely P; Kiss E
Orv Hetil; 2010 May; 151(18):735-40. PubMed ID: 20410000
[TBL] [Abstract][Full Text] [Related]
37. [Biologics in SLE].
Karonitsch T; Aringer M
Wien Med Wochenschr; 2015 Jan; 165(1-2):40-5. PubMed ID: 25411010
[TBL] [Abstract][Full Text] [Related]
38. [New biological therapy in systemic lupus erythematosus].
Morita K; Fujio K
Nihon Rinsho; 2012 Nov; 70 Suppl 8():539-44. PubMed ID: 23513898
[No Abstract] [Full Text] [Related]
39. Belimumab, a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus.
Espinosa G; Cervera R
Drugs Today (Barc); 2010 Dec; 46(12):891-9. PubMed ID: 21589946
[TBL] [Abstract][Full Text] [Related]
40. Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus.
Faria RM; Isenberg DA
Lupus; 2010 Sep; 19(10):1256-7. PubMed ID: 20534646
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
